Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04322162 · ClinicalTrials.gov registry record · NA
Addressing Sleep Apnea Post-Stroke/TIA
A NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 2
- Study locations
NCT04322162 is a NA study of Obstructive Sleep Apnea and Ischemic Stroke that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 6 participants, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04322162, a NA study of Obstructive Sleep Apnea and Ischemic Stroke, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 2
- Study locations
Study Summary
Effectively identifying and treating risk factors for ischemic stroke and transient ischemic attack (TIA) is important to patients, their family members, and healthcare systems. While obstructive sleep apnea (OSA) is a known risk factor for stroke and TIA that is present in more than 70% of stroke/TIA survivors, testing for OSA is infrequently performed for patients and within healthcare systems. The Addressing Sleep Apnea Post-Stroke/TIA (ASAP) study intends to improve rates of guideline-recommended OSA testing and treatment through local quality improvement initiatives (QI) conducted within and across 6 VA Medical Centers. ASAP will also determine the impact of these local QI initiatives on rates of OSA diagnosis, OSA treatment, recurrent vascular events, and hospital readmissions.
Conditions Studied
Interventions
- OTHER ASAP Intervention Quality Improvement Protocol
Study Locations (2)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Indiana
- Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-04-02 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04322162
The ClinicalTrials.gov registry entry for NCT04322162 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 222-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (97% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which ASAP Intervention Quality Improvement Protocol is the first listed.
NCT04322162 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Indiana.
Frequently Asked Questions
What is clinical trial NCT04322162 about?
NCT04322162 is a clinical study titled "Addressing Sleep Apnea Post-Stroke/TIA". Effectively identifying and treating risk factors for ischemic stroke and transient ischemic attack (TIA) is important to patients, their family members, and healthcare systems. While obstructive sleep apnea (OSA) is a known risk factor for stroke and TIA that is present in more than 70% of stroke/T...
What is the current status of trial NCT04322162?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2020-04-02. Estimated completion is 2024-07-31.
What conditions does trial NCT04322162 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Ischemic Stroke, Transient Ischemic Attack (TIA).
What interventions are being tested in trial NCT04322162?
The interventions under investigation include: ASAP Intervention Quality Improvement Protocol (OTHER).
Who is sponsoring clinical trial NCT04322162?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04322162 being conducted?
This trial has 2 study locations across Connecticut, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.